Notice of NIAMS Policy for Submission of Applications Containing Clinical Trials

Notice Number: NOT-AR-13-015

Key Dates
Release Date: April 3, 2013

Related Announcements

Issued by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)


The purpose of this Notice is to advise the extramural community that, effectively immediately, NIAMS will not accept investigator-initiated R01 applications and subsequent revisions containing clinical trials submitted to PA-11-260 "Research Project Grant (Parent R01)". Applicants submitting investigator-initiated applications to NIAMS that contain a clinical trial must respond to one of the NIAMS funding opportunity announcements (FOAs) specifically designed for clinical trials, the descriptions of which may be found at the following link:

A clinical trial is a prospective biomedical or behavioral research study of human subjects designed to answer specific questions about the safety, tolerability, efficacy and/or effectiveness of pharmacologic, behavioral, biologic, surgical, or device (invasive or non-invasive) interventions.

This policy does not apply to future NIAMS-specific FOAs that solicit clinical trials.


Please direct all inquiries to:

Laura K. Moen, Ph.D.
Director, Division of Extramural Research Activities
National Institute of Arthritis and Musculoskeletal and Skin Diseases
One Democracy Plaza
6701 Democracy Blvd, Suite 800
Bethesda, MD 20892
Telephone: 301-451-6515